Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and desogestrel

cetylpyridinium chloride anhydrous has been researched along with desogestrel in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ory, HW1

Other Studies

4 other study(ies) available for cetylpyridinium chloride anhydrous and desogestrel

ArticleYear
Pill research results in new guidance from CSM.
    Family planning today, 1995

    Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases

1995
Epidemiology of venous thromboembolic disease and OC use.
    Dialogues in contraception, 1996,Fall, Volume: 5, Issue:1

    Topics: Bias; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Disease; Embolism; Epidemiology; Family Planning Services; Health; Public Health; Research; Research Design; Risk Factors; Thromboembolism; Vascular Diseases

1996
Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
    Contraceptive technology update, 1997, Volume: 18, Issue:12

    Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Developed Countries; Disease; Embolism; England; Europe; Family Planning Services; Health; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases

1997
2 methods for prescribing third-generation OCs.
    Contraceptive technology update, 1997, Volume: 18, Issue:12

    Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Desogestrel; Developed Countries; Disease; Drug Prescriptions; Embolism; Europe; Family Planning Services; Health; Health Personnel; Health Planning; Health Planning Guidelines; Organization and Administration; Physicians; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases

1997